A Clinical Study to Limit Physiologic Intestinal FDG Uptake Uptake on PET-CT Scans
N/A
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Both
Intestinal FDG Uptake
Both
Intestinal FDG Uptake
Trial Information
A Clinical Study to Limit Physiologic Intestinal FDG Uptake Uptake on PET-CT Scans
Inclusion Criteria:
- Patients undergoing clinically-indicated PET-CT scan for non-GI lymphoma
Exclusion Criteria:
- Patients with known Inflammatory Bowel Disease
- Patients with known colon cancer
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Outcome Measure:
SUVmax of FDG in each colonic segment
Outcome Time Frame:
Day 2
Safety Issue:
No
Authority:
United States: Food and Drug Administration
Study ID:
2010-P-000101
NCT ID:
NCT01542541
Start Date:
July 2011
Completion Date:
October 2012
Related Keywords:
- Intestinal FDG Uptake
Name | Location |
|---|---|
| Beth Israel Deaconess Medical Center | Boston, Massachusetts 02215 |
